Comparison of 12-Week Additional Effect Features of Formoterol Co-Inhalation and Tulobuterol Patch on Budesonide Inhalation in Elderly Patients With Asthma
| Autor: | Susumu Fukahori MD, PhD, Tetsuya Kawano MD, PhD, Yasushi Obase MD, PhD, Jun Iriki MD, Tomoko Tsuchida-Yabe MD, PhD, Shinya Tomari MD, PhD, Chizu Fukushima MD, PhD, Hiroto Matsuse MD, PhD, Hiroshi Mukae MD, PhD |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2020 |
| Předmět: | |
| Zdroj: | Allergy & Rhinology, Vol 11 (2020) |
| Druh dokumentu: | article |
| ISSN: | 2152-6567 21526567 |
| DOI: | 10.1177/2152656720980416 |
| Popis: | Background For asthma strategy, to avoid the aggravation of bronchial inflammation and contraction, the long acting beta agonist (LABA) addition on inhaled corticosteroids (ICS) has been recommended. Objectives To know whether there is any clinical difference between the additional efficacies of Formoterol (FOR) and Tulobuterol (TUL) onto Budesonide (BUD) may be useful for the elderly patients’ asthma treatment strategy. Methods Eighteen outpatients with mild to moderate bronchial asthma with FEV1.0% |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|